Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
  2. Pahwa, Roma; Dubhashi, Janhavi; Singh, Anand; Jailwala, Parthav; Lobanov,Alexei; Thomas, Craig J; Ceribelli, Michele; Wilson, Kelli; Ricketts, Christopher J; Vocke, Cathy D; Wells, Catherine; Bottaro, Donald P; Linehan, W Marston; Neckers, Len; Srinivasan, Ramaprasad
  3. Journal of Experimental & Clinical Cancer Research : CR. 2022, Jun 27; 41(1): 208.
  1. 2.   Characterizing the tumor microenvironment in rare renal cancer histological types
  2. Synnott, Naoise C; Poeta, Maria Luana; Costantini, Manuela; Pfeiffer, Ruth M; Li, Mengying; Golubeva,Yelena; Lawrence, Scott; Mutreja,Karun; Amoreo, Carla; Dabrowska, Malgorzata; Simone, Giuseppe; Pescarmona, Edoardo; Lenz,Petra; Olanich, Mary; Duggan, Maire; Abubakar, Mustapha; Fazio, Vito Michele; Gallucci, Michele; Sentinelli, Steno; Landi, Maria Teresa
  3. The Journal of Pathology. Clinical Research. 2021, Oct 07;
  1. 3.   Clinical and Molecular Characterization of Microphthalmia-Associated Transcription Factor (MITF)-Related Renal Cell Carcinoma
  2. Lang, Martin; Vocke, Cathy D; Ricketts, Christopher J; Metwalli, Adam R; Ball, Mark W; Schmidt,Laura; Linehan, W Marston
  3. Urology. 2021, Mar; 149: 89-97.
  1. 4.   The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
  2. Ricketts, Christopher J; De Cubas, Aguirre A; Fan, Huihui; Smith, Christof C; Lang, Martin; Reznik, Ed; Bowlby, Reanne; Gibb, Ewan A; Akbani, Rehan; Beroukhim, Rameen; Bottaro, Donald P; Choueiri, Toni K; Gibbs, Richard A; Godwin, Andrew K; Haake, Scott; Hakimi, A Ari; Henske, Elizabeth P; Hsieh, James J; Ho, Thai H; Kanchi, Rupa S; Krishnan, Bhavani; Kwaitkowski, David J; Lui, Wembin; Merino, Maria J; Mills, Gordon B; Myers, Jerome; Nickerson, Michael L; Reuter, Victor E; Schmidt, Laura S; Shelley, C Simon; Shen, Hui; Shuch, Brian; Signoretti, Sabina; Srinivasan, Ramaprasad; Tamboli, Pheroze; Thomas, George; Vincent, Benjamin G; Vocke, Cathy D; Wheeler, David A; Yang, Lixing; Kim, William T; Robertson, A Gordon; Spellman, Paul T; Rathmell, W Kimryn; Linehan, W Marston
  3. Cell Reports. 2018, Apr 03; 23(1): 313-326.e5.
  1. 5.   Cited1 and cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis
  2. Boyle, S.; Shioda, T.; Perantoni, A. O.; de Caestecker, M.
  3. Developmental Dynamics. 2007, Aug; 236(8): 2321-2330.
  1. 6.   Identification of the genes for kidney cancer: Opportunity for disease-specific targeted therapeutics
  2. Linehan, W. M.; Pinto, P. A.; Srinivasan, R.; Merino, M.; Choyke, P.; Choyke, L.; Coleman, J.; Toro, J.; Glenn, G.; Vocke, C.; Zbar, B.; Schmidt, L. S.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2007, Jan; 13(2): 671S-679S.
  1. 7.   Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning
  2. Plisov, S.; Tsang, M.; Shi, G. B.; Boyle, S.; Yoshino, K.; Dunwoodie, S. L.; Dawid, I. B.; Shioda, T.; Perantoni, A. O.; de Caestecker, M. P.
  3. Journal of the American Society of Nephrology. 2005, JUN; 16(6): 1632-1644.
  1. 8.   Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele
  2. Graveel, C.; Su, Y. L.; Koeman, J.; Wang, L. M.; Tessarollo, L.; Fiscella, M.; Birchmeier, C.; Swiatek, P.; Bronson, R.; Woude, G. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, DEC 7; 101(49): 17198-17203.
  1. 9.   Birt-Hogg-Dube syndrome, a genodermatosis that increases risk for renal carcinoma
  2. Schmidt, L. S.
  3. Current Molecular Medicine. 2004, DEC; 4(8): 877-885.
  1. 10.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 11.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 12.   Sensitivity of renal cell carcinoma to aminoflavone: Role of CYP1A1
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Hose, C.; Linehan, W. M.; Worrell, R.; Rubinstein, L.; Sausville, A.; Vistica, D. T.
  3. Journal of Urology. 2004 171(4): 1688-1697.
  1. 13.   Studying cancer families to identify kidney cancer genes
  2. Zbar, B.; Klausner, R.; Linehan, W. M.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 217-233.
  1. 14.   Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome
  2. Nickerson, M. L.; Warren, M. B.; Toro, J. R.; Matrosova, V.; Glenn, G.; Turner, M. L.; Duray, P.; Merino, M.; Choyke, P.; Pavlovich, C. P.; Sharma, N.; Walther, M.; Munroe, D.; Hill, R.; Maher, E.; Greenberg, C.; Lerman, M. I.; Linehan, W. M.; Zbar, B.; Schmidt, L. S.
  3. Cancer Cell. 2002 2(2): 157-164.
  1. 15.   Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
  2. Danilkovitch-Miagkova, A.; Zbar, B.
  3. Journal of Clinical Investigation. 2002 109(7): 863-867.
  1. 16.   Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods
  2. Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2001 17(3): 210-219.
  1. 17.   Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies
  2. Miller, M.; Ginalski, K.; Lesyng, B.; Nakaigawa, N.; Schmidt, L.; Zbar, B.
  3. Proteins-Structure Function and Genetics. 2001 44(1): 32-43.
  1. 18.   Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway
  2. Danilkovitch-Miagkova, A.; Miagkov, A.; Skeel, A.; Nakaigawa, N.; Zbar, B.; Leonard, E. J.
  3. Molecular and Cellular Biology. 2001 21(17): 5857-5868.
  1. 19.   A novel germ line juxtamembrane Met mutation in human gastric cancer
  2. Lee, J. H.; Han, S. U.; Cho, H.; Jennings, B.; Gerrard, B.; Dean, M.; Schmidt, L.; Zbar, B.; Vande Woude, G. F.
  3. Oncogene. 2000 19(43): 4947-4953.
  1. 20.   Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src
  2. Nakaigawa, N.; Weirich, G.; Schmidt, L.; Zbar, B.
  3. Oncogene. 2000 19(26): 2996-3002.
  1. 21.   Signature-based analysis of MET proto-oncogene mutations using DHPLC
  2. Nickerson, M. L.; Weirich, G.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2000 16(1): 68-76.
  1. 22.   Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer
  2. Ornstein, D. K.; Lubensky, I. A.; Venzon, D.; Zbar, B.; Linehan, W. M.; Walther, M. M.
  3. Journal of Urology. 2000 163(2): 431-433.
  1. 23.   Novel mutations of the MET proto-oncogene in papillary renal carcinomas
  2. Schmidt, L.; Junker, K.; Nakaigawa, N.; Kinjerski, T.; Weirich, G.; Miller, M.; Lubensky, I.; Neumann, H. P. H.; Brauch, H.; Decker, J.; Vocke, C.; Brown, J. A.; Jenkins, R.; Richard, S.; Bergerheim, U.; Gerrard, B.; Dean, M.; Linehan, W. M.; Zbar, B.
  3. Oncogene. 1999 18(14): 2343-2350.
  1. 24.   Hereditary papillary renal carcinoma: pathology and pathogenesis
  2. Schmidt, L.; Lubensky, I.; Linehan, W. M.; Zbar, B.
  3. Contributions to Nephrology. 1999 128: 11-27.
  1. 25.   The Heidelberg Classification of Renal Cell Tumours
  2. Kovacs, G.; Akhtar, M.; Beckwith, B. J.; Bugert, P.; Cooper, C. S.; Delahunt, B.; Eble, J. N.; Fleming, S.; Ljungberg, B.; Medeiros, L. J.; Moch, H.; Reuter, V. E.; Ritz, E.; Roos, G.; Schmidt, D.; Srigley, J. R.; Storkel, S.; Vandenberg, E.; Zbar, B.
  3. Journal of Pathology. 1997 183(2): 131-133.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel